Annual Cash & Cash Equivalents
$757.36M$6.03M+0.80%
Summary
- Current Value
- As of today, RGEN annual cash & cash equivalents is $757.36M, up +0.80% on
- Historical Performance
- RGEN annual cash & cash equivalents is up +25.43% over the past 3 years, and up +43.33% over the past 5 years
- All-Time High Comparison
- RGEN annual cash & cash equivalents is currently at its all-time high
- 3-Year Low Comparison
- RGEN annual cash & cash equivalents is +44.68% above its 3-year low of $523.46M reached on an earlier date
- Sector Comparison
- RGEN annual cash & cash equivalents is higher than 91.77% of companies in Healthcare sector
Cash and Cash Equivalents Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual Cash & Cash Equivalents | $757.36M | +0.8% | +25.4% | +43.3% | +5946.3% | |
| Quarterly Cash & Cash Equivalents | $748.75M | -4.5% | +30.6% | +35.3% | +1226.8% | |
| Price | $166.82 | +7.8% | +5.0% | -19.9% | +3717.4% | |
| Annual Current Assets | $1.07B | -4.1% | +14.4% | +66.1% | +1686.2% | |
| Annual Total Liabilities | $856.95M | -1.1% | +40.9% | +151.8% | +10000.0% | |
| Annual Working Capital | $939.25M | -0.8% | +68.8% | +58.3% | +1607.0% | |
| Annual Net Income | -$25.51M | -171.7% | -119.9% | -219.2% | -527.8% |
Cash and Cash Equivalents Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $757.36M | at high | |
| 5Y | $757.36M | at high | |
| All | $757.36M | at high |
Cash and Cash Equivalents Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $523.46M | N/A | +44.7% |
| 5Y | $523.46M | +44.7% | |
| All | $3.22M | >+9999.0% |
Cash and Cash Equivalents History
FAQ
What is the current annual cash & cash equivalents of RGEN?
As of today, RGEN annual cash & cash equivalents is $757.36M
What is 1-year change in RGEN annual cash & cash equivalents?
RGEN annual cash & cash equivalents is up +0.80% year-over-year
What is 3-year change in RGEN annual cash & cash equivalents?
RGEN annual cash & cash equivalents is up +25.43% over the past 3 years
How far is RGEN annual cash & cash equivalents from its all-time high?
RGEN annual cash & cash equivalents is currently at its all-time high
How does RGEN annual cash & cash equivalents rank versus sector peers?
RGEN annual cash & cash equivalents is higher than 91.77% of companies in Healthcare sector
When is RGEN next annual earnings release?
The next annual earnings release for RGEN is on
Quarterly Cash & Cash Equivalents
$748.75M$39.89M+5.63%
Summary
- Current Value
- As of today, RGEN quarterly cash & cash equivalents is $748.75M, up +5.63% on
- Historical Performance
- RGEN quarterly cash & cash equivalents is down -4.49% year-over-year, and up +30.59% over the past 3 years
- All-Time High Comparison
- RGEN quarterly cash & cash equivalents is currently -7.46% below its historical high of $809.15M set on
- 3-Year Low Comparison
- RGEN quarterly cash & cash equivalents is +24.04% above its 3-year low of $603.66M reached on
- Sector Comparison
- RGEN quarterly cash & cash equivalents is higher than 90.09% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly Cash & Cash Equivalents | $748.75M | +5.6% | -4.5% | +30.6% | +35.3% | |
| Annual Cash & Cash Equivalents | $757.36M | – | +0.8% | +25.4% | +43.3% | |
| Price | $166.82 | +12.1% | +7.8% | +5.0% | -19.9% | |
| Quarterly Current Assets | $1.10B | +3.8% | -3.1% | +15.0% | +57.4% | |
| Quarterly Total Liabilities | $840.62M | +0.1% | +3.3% | +34.0% | +139.2% | |
| Quarterly Working Capital | $965.35M | +3.4% | -5.7% | +77.9% | +49.5% | |
| Quarterly Net Income | $14.91M | +0.3% | +2380.0% | -63.1% | +2.5% |
Quarterly Cash & Cash Equivalents Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $757.36M | N/A | -1.1% |
| 3Y | $809.15M | -7.5% | |
| 5Y | $809.15M | -7.5% | |
| All | $809.15M | -7.5% |
Quarterly Cash & Cash Equivalents Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $697.23M | +7.4% | |
| 3Y | $603.66M | +24.0% | |
| 5Y | $573.36M | +30.6% | |
| All | $3.10M | >+9999.0% |
Quarterly Cash & Cash Equivalents History
FAQ
What is the current quarterly cash & cash equivalents of RGEN?
As of today, RGEN quarterly cash & cash equivalents is $748.75M
What is RGEN quarterly cash & cash equivalents most recent change?
RGEN quarterly cash & cash equivalents was up +5.63% on September 30, 2025
What is 1-year change in RGEN quarterly cash & cash equivalents?
RGEN quarterly cash & cash equivalents is down -4.49% year-over-year
How far is RGEN quarterly cash & cash equivalents from its all-time high?
RGEN quarterly cash & cash equivalents is currently -7.46% below its historical high of $809.15M set on June 30, 2024
How does RGEN quarterly cash & cash equivalents rank versus sector peers?
RGEN quarterly cash & cash equivalents is higher than 90.09% of companies in Healthcare sector
When is RGEN next earnings release?
The next earnings release for RGEN is on
Cash and Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
Data Sources & References
- RGEN Official Website www.repligen.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/730272/000119312525252385/0001193125-25-252385-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/730272/000095017025038999/0000950170-25-038999-index.htm
- RGEN Profile on Yahoo Finance finance.yahoo.com/quote/RGEN
- RGEN Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/rgen